TFR1 as a Biomarker of Pulmonary Fibrosis Development in COPD Patients
In summary, these results indicated that serum TFR1 levels related to the severity of pulmonary fibrosis in clinical practice and may provide a potential target for the treatment of pulmonary fibrosis development from patients with COPD in the future.
Authors
- Nanjiang Zhou (ORCID: https://orcid.org/0000-0002-4083-0717)
- Cuizhong Liu (ORCID: https://orcid.org/0000-0003-1056-4208)
- Yu Jiang (ORCID: https://orcid.org/0000-0002-2645-3804)
- Aoguo Zeng
- Bin Xiao
- Yuan Wu
- Lijun Xie (ORCID: https://orcid.org/0000-0002-3618-8549)
Institutions
- Hunan Normal University (CN)
- Hunan Provincial People's Hospital (CN)
Publication Details
- Journal
- International Journal of COPD
- Published
- 2025-08-01
- DOI
- https://doi.org/10.2147/copd.s527782
- Citations
- 1
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 1.52